+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Transplantation Market by Product, Application, End User, and by Region - Global Forecast to 2022-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717225
The transplantation market size is estimated to be USD 12,607.1 million in 2022 and is expected to witness a CAGR of 9.67% during the forecast period 2023-2033. Surge in the prevalence of acute diseases, the development of technologically advanced products, and increase in the number of tissue banks are some of the factors contributing to the market growth. Furthermore, rise in incidence of organ failure and growing acceptance of tissue and organ transplantation are other factors supporting the market growth. However, lack of organs for the treatment of organ failure is expected to hinder the growth.

Rise in incidence of organ failure is expected to fuel the market growth during the projected. Growing alcohol and other drug use, along with an unhealthy diet that is creating many chronic diseases that lead to the failure of important organs such as the lungs, kidney, liver, and many others are all contributing to a rise in the incidence of organ failure. Transplantation market revenue growth is being fueled by the need for organ transplants among patients. Additionally, market revenue growth is being driven by technological developments in transplantation procedures.

Growing acceptance of tissue and organ transplantation during the forecast period as a result of ongoing advancements in surgical technology, better healthcare facilities, and raised public awareness of organ donation. The expansion of tissue banks and the creation of technologically advanced devices are propelling the market's revenue growth. In the transplantation market, market revenue growth is predicted to be fueled by the development of revolutionary 3D printing technology that aims to produce an organ or tissue that is comparable to the one already there in the body.

Segmentation

By Product

The market is categorized into preservation solution, tissue products, and immunosuppressive drugs. In 2022, the tissue products segment accounted for the highest revenue share due to rising demand for tissue and organ transplants. A huge population is now at risk of irreversible tissue damage due to a rise in the number of diseases such as diabetes, cancer, cardiovascular disease, renal disease, and Alzheimer's disease. This has expanded the demand for tissue transplantation, which is boosting the segment's revenue growth. The market for immunosuppressive drugs is anticipated to increase profitably during the research period. This is due to the widespread use of these drugs to stop the rejection of post-transplant tissue or organs. Globally, growing demand for organ replacement due to the frequency of chronic diseases. Therefore, during the projection period, the demand for immunosuppressive drugs is anticipated to increase significantly.

By Application

The market is categorized into tissue transplantation and organ transplantation. In the global market, the tissue transplantation segment accounted for the largest revenue share in 2022 owing to most frequent surgical procedures being the replacement of the skin, cornea, bones, heart valves, tendons, nerves, and veins. The need for tissue products is anticipated to increase as burn and accident cases rise. The organ transplantation segment is anticipated to increase at a profitable rate during the projection period. Immunosuppressant repurchases and the rising frequency of organ transplants worldwide are both expected to accelerate market expansion in the coming years. The number of transplant surgeries, including involving the kidney, liver, heart, lungs, and tissues, is anticipated to increase as transplantation technology improves and manufacturers introduce new products. For instance, in November 2020, Lupin announced the release of the generic immunosuppressant drug Tacrolimus on the American market, which is intended to prevent organ rejection in kidney, allogeneic liver, and heart transplants.

By End User

The market is divided into transplant centers, hospitals, and others. In 2022, the hospitals segment accounted for the largest revenue share owing to increasing number of medical treatments and surgeries carried out in hospitals. Most hospitals have easier access to well-defined organ databases that can be used to confirm the availability of requested organs, enabling faster medical assistance that is fueling the segment's revenue growth. The number of transplant centres is anticipated to expand at the fastest rate during the projected period. Growing transplantation operations have created a demand for more healthcare facilities to meet patients' unmet demands. Additionally, expanding government programmes to promote organ donation are anticipated to spur market expansion. For instance, the Division of Transplantation of the Health Resources and Services Administration supported four funding programmes with the objective of increasing organ donation rates and transplant procedures. The developed healthcare systems in the United States, France, the United Kingdom, and other European nations have boosted the demand for improved transplant products for the management of organ failure and tissue replacement. Furthermore, these regions are witnessing an increase in the number of advanced transplant centers.

Regional Markets

In 2022, North America region accounted for the highest revenue in the transplantation market and is expected to maintain its dominance during the forecast period. This is attributed to the ongoing development of novel transplantation products for treatment, established healthcare system, and rising consumer spending on personal health. The strong presence of numerous large-scale biotechnology and medical device companies is also anticipated to fuel the market's revenue growth in North America. Furthermore, the industry in this region is growing in terms of revenue due to favorable government policies in the US and Canada. The market in Asia Pacific is anticipated to have higher revenue growth during the projection period. One of the main factors propelling the market's revenue growth in this region is the increasing rate of various chronic diseases and the rising frequency of traffic accidents, which permanently damage organs and necessitate replacing them with healthy organs in order to preserve the patient's life. The expansion of the Asia Pacific transplantation market's revenue is also being driven by leading companies' ongoing improvements in transplantation technology in these countries.

Competitor Insights

Some of the key players operating in the transplantation market are Medtronic, Arthrex, Inc., AbbVie, Inc., Zimmer Biomet, Stryker, Teva Pharmaceuticals, 21st Century Medicine, Novartis AG, BioLifeSolutions, Inc, and Veloxis Pharmaceuticals.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

The Swedish company Hansa Biopharma AB announced in February 2022, the French Haute Autorité de Santé (HAS) has granted Idefirix its approval. Idefirix will be used by the company to desensitise extremely sensitive patients getting kidney transplants.

The Washington, DC-based national non-profit organisation Kidney Transplant Collaborative (KTC) was officially formed on September 1, 2021. The kidney transplantation center, or KTC, is a non-profit organisation that operates to increase kidney transplantation while lowering barriers, such as cost, that recipients and donors face during the transplantation procedure.This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, application, and end user from 2023 to 2033.

Segmentation: Transplantation Market Report 2022 - 2033

Product (Revenue, USD Million), 2022 - 2033

  • Preservation Solution
  • Tissue Products
  • Immunosuppressive Drugs

Application (Revenue, USD Million), 2022 - 2033

  • Tissue Transplantation
  • Organ Transplantation

End user (Revenue, USD Million), 2022 - 2033

  • Transplant Centers
  • Hospitals
  • Others

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Transplantation

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Transplantation Market

7. Market Analysis by Product
7.1. Preservation Solution
7.1.1. Preservation Solution Market Forecast, 2022-2033 (USD Million)
7.2. Tissue Products
7.2.1. Tissue Products Market Forecast, 2022-2033 (USD Million)
7.3. Immunosuppressive Drugs
7.3.1. Immunosuppressive Drugs Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by Application
8.1. Tissue Transplantation
8.1.1. Tissue Transplantation Market Forecast, 2022-2033 (USD Million)
8.2. Organ Transplantation
8.2.1. Organ Transplantation Market Forecast, 2022-2033 (USD Million)

9. Market Analysis by End User
9.1. Transplant Centers
9.1.1. Transplant Centers Market Forecast, 2022-2033 (USD Million)
9.2. Hospitals
9.2.1. Hospitals Market Forecast, 2022-2033 (USD Million)
9.3. Others
8.1.1. Others Market Forecast, 2022-2033 (USD Million)

9. Regional Market Analysis
9.1. Regional Market Trends Analysis

10. North America Transplantation Market
10.1. North America Transplantation Market
10.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.2. U.S. Transplantation Market
10.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.3. Canada Transplantation Market
10.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

11. Europe Transplantation Market
11.1. Europe Transplantation Market
11.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.2. Germany Transplantation Market
11.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.3. UK Transplantation Market
11.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.4. France Transplantation Market
11.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.5. Spain Transplantation Market
11.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.6. Italy Transplantation Market
11.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.6.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.7. Rest of Europe Transplantation Market
11.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.7.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

12. Asia Pacific Transplantation Market
12.1. Asia Pacific Transplantation Market
12.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.2. Japan Transplantation Market
12.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.3. China Transplantation Market
12.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.4. India Transplantation Market
12.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.5. South Korea Transplantation Market
12.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.6. Australia Transplantation Market
12.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
12.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.6.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.6.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.7. Rest of Asia Pacific Transplantation Market
12.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
12.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.7.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.7.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

13. Latin America Transplantation Market
13.1. Latin America Transplantation Market
13.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.2. Brazil Transplantation Market
13.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.3. Mexico Transplantation Market
13.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.4. Argentina Transplantation Market
13.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.5. Rest of Latin America Transplantation Market
13.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
13.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

14. MEA Transplantation Market
14.1. MEA Transplantation Market
14.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
14.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
14.2. GCC Transplantation Market
14.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
14.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
14.3. South Africa Transplantation Market
14.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
14.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
14.4. Rest of MEA Transplantation Market
14.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
14.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

15. Competitor Analysis
15.1. Market Share Analysis, 2022
15.2. Major Recent Developments, 2019-2022

16. Company Profiles
16.1. Medtronic
16.1.1. Company Snapshot
16.1.2. Company Overview
16.1.3. Financial Analysis
16.1.4. Product Benchmarking
16.1.5. Recent Developments
16.2. Arthrex, Inc.
16.2.1. Company Snapshot
16.2.2. Company Overview
16.2.3. Financial Analysis
16.2.4. Product Benchmarking
16.2.5. Recent Developments
16.3. AbbVie, Inc.
16.3.1. Company Snapshot
16.3.2. Company Overview
16.3.3. Financial Analysis
16.3.4. Product Benchmarking
16.3.5. Recent Developments
16.4. Zimmer Biomet
16.4.1. Company Snapshot
16.4.2. Company Overview
16.4.3. Financial Analysis
16.4.4. Product Benchmarking
16.4.5. Recent Developments
16.5. Stryker
16.5.1. Company Snapshot
16.5.2. Company Overview
16.5.3. Financial Analysis
16.5.4. Product Benchmarking
16.5.5. Recent Developments
16.6. Teva Pharmaceuticals
16.6.1. Company Snapshot
16.6.2. Company Overview
16.6.3. Financial Analysis
16.6.4. Product Benchmarking
16.6.5. Recent Developments
16.7. 21st Century Medicine
16.7.1. Company Snapshot
16.7.2. Company Overview
16.7.3. Financial Analysis
16.7.4. Product Benchmarking
16.7.5. Recent Developments
16.8. Novartis AG
16.8.1. Company Snapshot
16.8.2. Company Overview
16.8.3. Financial Analysis
16.8.4. Product Benchmarking
16.8.5. Recent Developments
16.9. BioLifeSolutions, Inc
16.9.1. Company Snapshot
16.9.2. Company Overview
16.9.3. Financial Analysis
16.9.4. Product Benchmarking
16.9.5. Recent Developments
16.10. Veloxis Pharmaceuticals
16.10.1. Company Snapshot
16.10.2. Company Overview
16.10.3. Financial Analysis
16.10.4. Product Benchmarking
16.10.5. Recent Developments
16.11. Company 11
16.11.1. Company Snapshot
16.11.2. Company Overview
16.11.3. Financial Analysis
16.11.4. Product Benchmarking
16.11.5. Recent Developments
16.12. Company 12
16.12.1. Company Snapshot
16.12.2. Company Overview
16.12.3. Financial Analysis
16.12.4. Product Benchmarking
16.12.5. Recent Developments
16.13. Company 13
16.13.1. Company Snapshot
16.13.2. Company Overview
16.13.3. Financial Analysis
16.13.4. Product Benchmarking
16.13.5. Recent Developments
16.14. Company 14
16.14.1. Company Snapshot
16.14.2. Company Overview
16.14.3. Financial Analysis
16.14.4. Product Benchmarking
16.14.5. Recent Developments
16.15. Company 15
16.15.1. Company Snapshot
16.15.2. Company Overview
16.15.3. Financial Analysis
16.15.4. Product Benchmarking
16.15.5. Recent Developments

17. Conclusion

18. Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Medtronic
  • Arthrex Inc.
  • AbbVie Inc.
  • Zimmer Biomet
  • Stryker
  • Teva Pharmaceuticals
  • 21st Century Medicine
  • Novartis AG
  • BioLifeSolutions Inc
  • Veloxis Pharmaceuticals.